Finance

Beta
Lists
ERIS:NSE
Eris Lifesciences Ltd
₹1,353.40
-0.59%
(-8.00) 1D
May 27, 3:30:02 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ERIS...
Open
₹1,362.20
High
₹1,374.90
Low
₹1,350.00
Mkt. cap
187.54B
Avg. vol.
186.87K
Volume
37.42K
Dividend
0.53%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
29.90
52-wk high
₹1,910.00
52-wk low
₹1,200.00
EPS
₹45.26
Shares outstanding
137.52M
No. of employees
3K
Open
₹1,362.20
High
₹1,374.90
Low
₹1,350.00
Mkt. cap
187.54B
Avg. vol.
186.87K
Volume
37.42K
Dividend
0.53%
Quarterly dividend
₹1.80
Ex-dividend date
Feb 13, 2025
P/E ratio
29.90
52-wk high
₹1,910.00
52-wk low
₹1,200.00
EPS
₹45.26
Shares outstanding
137.52M
No. of employees
3K
News stories
From sources across the web
About Eris Lifesciences Ltd
CEO-
Employees3.35K
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteeris.co.in
Last report
May 20, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹20.57 / ₹8.67
+137.35%beat
Revenue / Est. (INR)
7.52B / 8.08B
-6.94%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
7.72B
7.90B
8.01B
7.52B
Cost of goods sold
1.85B
2.02B
2.23B
1.85B
Cost of revenue
1.85B
2.02B
2.23B
1.85B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.44B
1.37B
1.38B
1.37B
Operating expense
3.81B
3.69B
3.66B
3.63B
Total operating expenses
5.65B
5.71B
5.90B
5.48B
Operating income
2.06B
2.19B
2.11B
2.04B
Other non operating income
26.90M
28.10M
200.00K
22.30M
EBT including unusual items
1.61B
1.73B
1.45B
1.59B
EBT excluding unusual items
1.61B
1.73B
1.63B
1.59B
Income tax expense
360.00M
382.00M
365.20M
-1.20B
Effective tax rate
22.35%
22.12%
25.13%
-75.08%
Other operating expenses
1.66B
1.62B
1.58B
1.57B
Net income
1.18B
1.20B
997.20M
2.82B
Net profit margin
15.29%
15.21%
12.45%
37.43%
Earnings per share
8.64
8.81
8.26
20.57
Interest and investment income
-
-
-
-
Interest expense
-486.80M
-495.50M
-488.20M
-456.20M
Net interest expenses
-486.80M
-495.50M
-488.20M
-456.20M
Depreciation and amortization charges
705.10M
690.80M
703.40M
695.70M
EBITDA
2.82B
2.89B
2.87B
2.74B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer